Banked under cGMP and suitable for use in clinical programs. Complete FDA points to consider testing including virus testing has been performed. Karyotype, STR, and marker expression were performed both at thaw and at P+10 (End of Production testing). Resulting karyotype data for the extended culture suggests that there may be a very small subpopulation of cells with a gain in chromosome 20q present in the cGMP bank material. Complete testing data is included as a PDF in the table below under Product Information and Testing. To request this material please contact [email protected].